Is This Small-Cap Medical Devices Stock a Buy?
Shares of medical instruments and supplies company AngioDynamics (NASDAQ: ANGO) have plunged nearly 25% in 2022, significantly underperforming the S&P 500, which is also down 7% this year.
Was the sell-off of AngioDynamics stock justified? More importantly, could its shares be a buy for growth investors at the current price? Let's dig into the company's fundamentals and valuation to address these questions.
Image source: Getty Images.
Source Fool.com